§ Same category · GLP-1 / metabolic peptides
Retatrutide vs Tesofensine
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Retatrutide
13
vendors tracked
from $2.83/mg
Tesofensine
1
vendors tracked
from $239.98/mg
◎ Cheapest $/mg:Retatrutide at $2.83/mg
Retatrutide
Triple GCG/GIP/GLP-1 agonist
B
Operational$54.50
$5.45/mg
In stock◎ Best $/mg
B
Operational$59.99
$6.00/mg
In stockOn sale▲ 10.1% vs best
B-
Operational$78.00
$7.80/mg
In stock▲ 43.1% vs best
Operational
$99.99
$10.00/mg
In stock▲ 83.5% vs best
Operational
$107.25
$10.72/mg
In stock▲ 96.8% vs best
B-
Operational$109.00
$10.90/mg
In stock▲ 100.0% vs best
Watch
$109.00
$10.90/mg
In stock▲ 100.0% vs best
Watch
$129.99
$13.00/mg
In stock▲ 138.5% vs best
Operational
$188.99
$18.90/mg
In stock▲ 246.8% vs best
Operational
$199.97
$20.00/mg
In stock▲ 266.9% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Welli Labs US | B | Operational | $54.50 ◎ Best $/mg | $5.45 | In stock | Buy with code → | |
| MS Peptides US | B | Operational | $59.99 On sale ▲ 10.1% | $6.00 | In stock | Visit → | |
| Purus Peptides US | B- | Operational | $78.00 ▲ 43.1% | $7.80 | In stock | Visit → | |
| Peptira US | B | Operational | $99.00 ▲ 81.7% | $9.90 | In stock | Visit → | |
| One Day Compounds US | B- | Operational | $99.99 ▲ 83.5% | $10.00 | In stock | Visit → | |
| Australian Peptides AU | B- | Operational | $107.25 ▲ 96.8% | $10.72 | In stock | Visit → | |
| Atomik Labz US | B- | Operational | $109.00 ▲ 100.0% | $10.90 | In stock | Visit → | |
| Solution Peptides US | B- | Watch | $109.00 ▲ 100.0% | $10.90 | In stock | Visit → | |
| Felix Chemical Supply US | B- | Watch | $129.99 ▲ 138.5% | $13.00 | In stock | Visit → | |
| Research Peptides Europe EU | A | Operational | $188.99 ▲ 246.8% | $18.90 | In stock | Visit → | |
| Pure Lab Peptides US | B- | Operational | $199.97 ▲ 266.9% | $20.00 | In stock | Visit → |
Sort:
Last crawl 2026-08-13Sort:
2026-08-13Tesofensine
Triple monoamine reuptake inhibitor
No current listings at 1mg.
About Retatrutide
An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.
About Tesofensine
A serotonin-noradrenaline-dopamine reuptake inhibitor studied for obesity. Approved for obesity in Mexico; investigational elsewhere.